Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study

por Panarelli, Joseph F., Bowden, Eileen C., Tepedino, Michael E., Odani-Kawabata, Noriko, Pei, Zifan, McLaurin, Eugene B., Ropo, Auli
Publicado 2023

Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study

por Schwab, Dietmar, Sturm, Carolina, Portron, Agnès, Fuerst-Recktenwald, Sabine, Hainzl, Dominik, Jordan, Paul, Stewart, William C, Tepedino, Michael E, DuBiner, Harvey
Publicado 2017